Response to ‘Letter to the Editor: Weight gain and metabolic screening in young people with early psychosis on long acting injectable antipsychotic medication’

Documenti analoghi

• Validating cognitive screening in young people with first‐episode psychosis: The CogScreen protocol
  di: Alexandra Stainton, et al.
  Pubblicazione: (2024)
• Implementation of a lifestyle and life‐skills intervention to prevent weight‐gain and cardiometabolic abnormalities in young people with first‐episode psychosis as part of routine care: The Keeping the Body in Mind program
  di: Jackie Curtis, et al.
  Pubblicazione: (2024)
• An open label pilot trial of low‐dose lithium for young people at ultra‐high risk for psychosis
  di: Simon M. Rice, et al.
  Pubblicazione: (2024)
• Psychometric properties of the Spanish version of the measure of insight into cognition‐self‐report in psychosis‐risk and non‐clinical Mexican young adults
  di: Ana Fresán, et al.
  Pubblicazione: (2024)
• Pathways to care in youth and young adults at clinical high risk for psychosis in Switzerland: Current situation and clinical implementation of the PsyYoung project
  di: Barbara Bailey, et al.
  Pubblicazione: (2024)